IN2014MU01191A - - Google Patents

Info

Publication number
IN2014MU01191A
IN2014MU01191A IN1191MU2014A IN2014MU01191A IN 2014MU01191 A IN2014MU01191 A IN 2014MU01191A IN 1191MU2014 A IN1191MU2014 A IN 1191MU2014A IN 2014MU01191 A IN2014MU01191 A IN 2014MU01191A
Authority
IN
India
Prior art keywords
anagliptin
preparation
short
relates
present
Prior art date
Application number
Inventor
Naveen Reddy
Damodara Naidu
Pramodkumar Sharma
Bhatraju Srinivasa Rao
Keshav Deo
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Priority to IN1191MU2014 priority Critical patent/IN2014MU01191A/en
Priority to PCT/IB2014/066940 priority patent/WO2015150887A1/en
Publication of IN2014MU01191A publication Critical patent/IN2014MU01191A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates to a short and industrially advantageous process for the preparation of Anagliptin.
IN1191MU2014 2014-03-29 2014-12-16 IN2014MU01191A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN1191MU2014 IN2014MU01191A (en) 2014-03-29 2014-12-16
PCT/IB2014/066940 WO2015150887A1 (en) 2014-03-29 2014-12-16 Process for the preparation of anagliptin or its salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1191MU2014 IN2014MU01191A (en) 2014-03-29 2014-12-16

Publications (1)

Publication Number Publication Date
IN2014MU01191A true IN2014MU01191A (en) 2015-10-02

Family

ID=54239455

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1191MU2014 IN2014MU01191A (en) 2014-03-29 2014-12-16

Country Status (2)

Country Link
IN (1) IN2014MU01191A (en)
WO (1) WO2015150887A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595866B1 (en) 2003-01-31 2016-06-08 Sanwa Kagaku Kenkyusho Co., Ltd. Cyanopyrrolidines useful for the treatment of inter alia metabolic syndrome
EP1833480A2 (en) 2004-11-30 2007-09-19 Artesian Therapeutics, Inc. Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
WO2009047240A1 (en) 2007-10-09 2009-04-16 Smithkline Beecham Corporation Indole derivatives useful as ppar activators
JP2010064982A (en) 2008-09-10 2010-03-25 Dainippon Sumitomo Pharma Co Ltd Alkylamino derivative
AR077468A1 (en) 2009-07-09 2011-08-31 Array Biopharma Inc PIRAZOLO COMPOUNDS (1,5-A) PYRIMIDINE SUBSTITUTED AS TRK-QUINASA INHIBITORS
AU2010291834A1 (en) 2009-09-04 2012-03-15 Zalicus Pharmaceuticals Ltd. Substituted heterocyclic derivatives for the treatment of pain and epilepsy
WO2011075699A2 (en) 2009-12-18 2011-06-23 Sunovion Pharmaceuticals Inc. Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
TW201412745A (en) * 2012-08-28 2014-04-01 Sanwa Kagaku Kenkyusho Co Crystal of N-[2-({2-[(2S)-2-cyanopyrrolidin-1-YL]-2- oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide

Also Published As

Publication number Publication date
WO2015150887A1 (en) 2015-10-08

Similar Documents

Publication Publication Date Title
IN2014CH00247A (en)
IL251613A0 (en) Process for the preparation of treprostinil
IN2013MU00646A (en)
PL3262023T3 (en) Process for the production of dienes
MX2017003301A (en) Refractory product, batch composition for producing said product, method for producing the product and use of said product.
IL248267B (en) Process for the preparation of substituted cycloserines
IN2014MU00455A (en)
SI3160985T1 (en) Process for the production of d-arginyl-2,6-dimethyl-l-tyrosyl-l-lysyl-l-phenylalaninamide
EP3237424A4 (en) Process of making cenicriviroc and related analogs
GB201509646D0 (en) Novel process
SG11201608513WA (en) Novel purification process of gonadotropin
PT3182981T (en) Process for the production of isomaltooligosaccharides
IL247443B (en) Process for the preparation of 5-fluorotryptophol
PL3271325T3 (en) Process of production of (s) -metolachlor
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
GB201607540D0 (en) Hydrcarbon production process
GB201416909D0 (en) Method of forming concentrated solution
MX380240B (en) PREPARATION OF PIPERIDIN-4-CARBOTHIOAMIDE.
WO2015118558A3 (en) Process for the preparation of clofarabine
IL252471A0 (en) A process for the manufacture of idalopirdine
IN2014MU01191A (en)
HUE039419T2 (en) Process for the preparation of ramipril
HUP1400518A2 (en) Process for the preparation of tofacitinib
IN2014CH01391A (en)
MX2018001296A (en) Process for the synthesis of ravidasvir.